热门资讯> 正文

mmuCell任命Olivier te Boekhorst为新任首席执行官

2025-11-05 05:28

伊芙美尔医疗(ICCC) 0

ImmuCell (NASDAQ:ICCC) announced on Tuesday that Olivier te Boekhorst will serve as President and CEO of the company effective November 1, 2025.
The company’s Board of directors appointed te Boekhorst to the Board of directors along with Timothy C. Fiori as CFO.
Olivier te Boekhorst will be succeeding Michael F. Brigham, but he will continue as a member of the Board and serve as a special advisor to the CEO until January of 2026.

More on ImmuCell

ImmuCell Corporation: At A Major Inflection Point
ImmuCell Corporation (ICCC) Q2 2025 Earnings Call Transcript
ImmuCell announces preliminary sales results for Q3
ImmuCell outlines cautious H2 outlook as capacity expansion supports First Defense suite
Seeking Alpha’s Quant Rating on ImmuCell

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。